SCOPUS 정보 검색 플랫폼

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 3, 2012, Pages 800-803

Inhibitory human antichimeric antibodies to rituximab in a patient with pemphigus

(2) Lunardon, Luisa a Payne, Aimee S a

a UNIVERSITY OF PENNSYLVANIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CHIMERIC ANTIBODY; RITUXIMAB;

ADULT; B LYMPHOCYTE; CASE REPORT; CELL SELECTION; CHEST TIGHTNESS; DIAPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUSHING; HUMAN; IRON DEFICIENCY ANEMIA; LETTER; PEMPHIGUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SWELLING; THROAT SWELLING; TONGUE SWELLING; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84865685132 PISSN: 00916749 EISSN: 10976825 Source Type: Journal
DOI: 10.1016/j.jaci.2012.03.022 Document Type: Article

Times cited : (36)

References (9)

1
- 34547761274
- A single cycle of rituximab for the treatment of severe pemphigus
- P. Joly, H. Mouquet, J.C. Roujeau, M. D'Incan, D. Gilbert, and S. Jacquot A single cycle of rituximab for the treatment of severe pemphigus N Engl J Med 357 2007 545 552
- (2007) N Engl J Med , vol.357 , pp. 545-552
- Joly, P.¹ Mouquet, H.² Roujeau, J.C.³ D'Incan, M.⁴ Gilbert, D.⁵ Jacquot, S.⁶

2
- 33750291236
- Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin
- A.R. Ahmed, Z. Spigelman, L.A. Cavacini, and M.R. Posner Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin N Engl J Med 355 2006 1772 1779
- (2006) N Engl J Med , vol.355 , pp. 1772-1779
- Ahmed, A.R.¹ Spigelman, Z.² Cavacini, L.A.³ Posner, M.R.⁴

3
- 56749153905
- Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
- D. Albert, J. Dunham, S. Khan, J. Stansberry, S. Kolasinski, and D. Tsai Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus Ann Rheum Dis 67 2008 1724 1731
- (2008) Ann Rheum Dis , vol.67 , pp. 1724-1731
- Albert, D.¹ Dunham, J.² Khan, S.³ Stansberry, J.⁴ Kolasinski, S.⁵ Tsai, D.⁶

4
- 4043179907
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab
- R.J. Looney, J.H. Anolik, D. Campbell, R.E. Felgar, F. Young, and L.J. Arend B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab Arthritis Rheum 50 2004 2580 2589
- (2004) Arthritis Rheum , vol.50 , pp. 2580-2589
- Looney, R.J.¹ Anolik, J.H.² Campbell, D.³ Felgar, R.E.⁴ Young, F.⁵ Arend, L.J.⁶

5
- 67649227736
- Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura
- S. Goto, H. Goto, R. Tanoshima, H. Kato, H. Takahashi, and O. Sekiguchi Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura Int J Hematol 89 2009 305 309
- (2009) Int J Hematol , vol.89 , pp. 305-309
- Goto, S.¹ Goto, H.² Tanoshima, R.³ Kato, H.⁴ Takahashi, H.⁵ Sekiguchi, O.⁶

6
- 25444437442
- Rituximab treatment in patients with primary Sjogren's syndrome: An open-label phase II study
- J. Pijpe, G.W. van Imhoff, F.K. Spijkervet, J.L. Roodenburg, G.J. Wolbink, and K. Mansour Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study Arthritis Rheum 52 2005 2740 2750
- (2005) Arthritis Rheum , vol.52 , pp. 2740-2750
- Pijpe, J.¹ Van Imhoff, G.W.² Spijkervet, F.K.³ Roodenburg, J.L.⁴ Wolbink, G.J.⁵ Mansour, K.⁶

7
- 67651154129
- Immunogenicity of rituximab in patients with severe pemphigus
- E. Schmidt, K. Hennig, C. Mengede, D. Zillikens, and A. Kromminga Immunogenicity of rituximab in patients with severe pemphigus Clin Immunol 132 2009 334 341
- (2009) Clin Immunol , vol.132 , pp. 334-341
- Schmidt, E.¹ Hennig, K.² Mengede, C.³ Zillikens, D.⁴ Kromminga, A.⁵

8
- 43449130884
- Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
- D.F. Murrell, S. Dick, A.R. Ahmed, M. Amagai, M.A. Barnadas, and L. Borradori Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus J Am Acad Dermatol 58 2008 1043 1046
- (2008) J Am Acad Dermatol , vol.58 , pp. 1043-1046
- Murrell, D.F.¹ Dick, S.² Ahmed, A.R.³ Amagai, M.⁴ Barnadas, M.A.⁵ Borradori, L.⁶

9
- 0642373290
- Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma
- W.K. Weng, and R. Levy Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma J Clin Oncol 21 2003 3940 3947
- (2003) J Clin Oncol , vol.21 , pp. 3940-3947
- Weng, W.K.¹ Levy, R.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.